FSCN1 and nasopharyngeal carcinoma: In our present study, we identified and verified that FSCN1 was a direct target of miR-145 using luciferase reporter assay, which was further confirmed by the findings that ectopic expression of miR-145 could inhibit the FSCN1 expression at both the mRNA and protein level, the expression of miR-145 was inversely correlated with FSCN1 expression in the clinical NPC samples.